Principal Investigator
Richard Preston
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20190510
Clinical Trial Summary
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Multiple Dose Study of Oral AVP-786 (Deudextromethorphan Hydrobromide/Quinidine Sulfate) Capsules in Adult Subjects with Normal and Impaired Renal Function
Protocol Number: 19-AVP-786-109
Phase
Phase I
Funding Agency/Sponsor
Industry
Disease
Other